We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
+45.97%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$7.07B
AUM Growth
+$1.91B
Cap. Flow
+$58.2M
Cap. Flow %
0.82%
Top 10 Hldgs %
40.22%
Holding
232
New
17
Increased
84
Reduced
52
Closed
24

Top Buys

Rank Stock Value
1
GBIO
Generation Bio
GBIO
+$32.1M
2
SYK icon
Stryker
SYK
+$27.9M
3
PODD icon
Insulet
PODD
+$24.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$24.3M
5
DVA icon
DaVita
DVA
+$23.4M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$78.8M
2
ISRG icon
Intuitive Surgical
ISRG
+$34.5M
3
ILMN icon
Illumina
ILMN
+$34.1M
4
MRNA icon
Moderna
MRNA
+$33.1M
5
AKCA
Akcea Therapeutics Inc
AKCA
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 96.05%
2 Industrials 0.58%
3 Technology 0.42%
4 Communication Services 0.29%
5 Financials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPGI icon
151
S&P Global
SPGI
$126B
$560K 0.01%
1,700
– –
FDS icon
152
Factset
FDS
$9.05B
$558K 0.01%
1,700
– –
MCO icon
153
Moody's
MCO
$82.4B
$549K 0.01%
2,000
– –
A icon
154
Agilent Technologies
A
$39.1B
$548K 0.01%
6,200
– –
TYL icon
155
Tyler Technologies
TYL
$12.2B
$529K 0.01%
1,525
– –
ANSS
156
DELISTED
Ansys
ANSS
$526K 0.01%
1,802
– –
JD icon
157
JD.com
JD
$40.8B
$524K 0.01%
8,700
-6,000
-41% -$304K
TRMB icon
158
Trimble
TRMB
$12.3B
$505K 0.01%
11,700
– –
ADI icon
159
Analog Devices
ADI
$181B
$503K 0.01%
4,100
– –
MKC icon
160
McCormick & Company Non-Voting
MKC
$13.4B
$502K 0.01%
5,600
– –
VAR
161
DELISTED
Varian Medical Systems, Inc.
VAR
$502K 0.01%
4,100
– –
WSO icon
162
Watsco Inc
WSO
$14.9B
$498K 0.01%
2,800
– –
CSGP icon
163
CoStar Group
CSGP
$11.3B
$497K 0.01%
7,000
– –
MELI icon
164
Mercado Libre
MELI
$91.3B
$493K 0.01%
+500
New +$375K
BF.B icon
165
Brown-Forman Class B
BF.B
$12B
$484K 0.01%
7,600
– –
STIM icon
166
Neuronetics
STIM
$120M
$483K 0.01%
250,000
-75,961
-23% -$156K
ADBE icon
167
Adobe
ADBE
$89.5B
$479K 0.01%
1,100
-400
-27% -$148K
SQM icon
168
Sociedad Química y Minera de Chile
SQM
$19.6B
$474K 0.01%
18,200
– –
HTHT icon
169
Huazhu Hotels Group
HTHT
$12.4B
$473K 0.01%
13,500
– –
SWKS icon
170
Skyworks Solutions
SWKS
$9.06B
$473K 0.01%
3,700
-2,000
-35% -$222K
RVTY icon
171
Revvity
RVTY
$12.3B
$471K 0.01%
4,800
– –
GGG icon
172
Graco
GGG
$12.9B
$466K 0.01%
9,700
– –
TRU icon
173
TransUnion
TRU
$14.8B
$444K 0.01%
5,096
– –
ICE icon
174
Intercontinental Exchange
ICE
$82.4B
$440K 0.01%
4,800
– –
ALV icon
175
Autoliv
ALV
$8.6B
$439K 0.01%
6,800
– –
5 6
7
8 9

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Bellevue Group's Q2 2020 Portfolio in Review

As of Q2 2020, Bellevue Group held 232 positions worth $7.07B, up 37% from $5.16B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Bellevue Group's Q2 2020 filing shows 17 new, 84 increased, 52 reduced and 24 closed positions. Its largest new stake was Generation Bio: 144,000 shares worth $30.2M. The largest sale was Vertex Pharmaceuticals, an estimated $78.8M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Industrials and Technology.

  • Bellevue Group's largest Q2 2020 buy was Generation Bio: 144,000 shares worth $30.2M.
  • Bellevue Group added most to Stryker in Q2 2020, an estimated $27.9M increase.
  • Bellevue Group's biggest Q2 2020 reduction was Vertex Pharmaceuticals, cutting an estimated $78.8M.
  • Bellevue Group fully exited QuidelOrtho in Q2 2020, selling an estimated $11.1M.
  • Bellevue Group's ten largest holdings make up 40% of its $7.07B portfolio in Q2 2020.
  • Bellevue Group opened 17 new positions and closed 24 in Q2 2020.
  • Bellevue Group's portfolio value rose 37% quarter-over-quarter to $7.07B.

Based on Bellevue Group's 13F filing for Q2 2020, filed 13 Aug 2020.